[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617873":3},{"organization":4,"outcomesModule":7,"designInfo":31,"detailedDescription":11,"studyPopulation":11,"armGroups":39,"interventions":53,"overallOfficials":11,"centralContacts":63,"locations":70,"responsibleParty":87,"collaborators":11,"id":91,"slug":92,"hasResults":93,"nctId":94,"briefTitle":95,"officialTitle":96,"acronym":11,"eligibilityCriteria":97,"healthyVolunteers":93,"sex":98,"minAge":99,"maxAge":100,"enrollmentInfo":101,"targetDuration":11,"studyType":104,"phases":105,"briefSummary":107,"conditions":108,"keywords":112,"overallStatus":73,"whyStopped":11,"lastUpdateSubmitDate":115,"lastUpdatePostDateStruct":116,"startDateStruct":119,"completionDateStruct":121,"leadSponsor":123,"locationsCount":124},{"fullName":5,"class":6},"I-Shou University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Fugl-Meyer Assessment",null,"Baseline, 2 weeks, 4 weeks, and 3 months post-intervention.",[14,17,19,21,23,25,27,29],{"measure":15,"description":11,"timeFrame":16},"Grip and pinch power","Baseline, 4 weeks, and 3 months post-intervention.",{"measure":18,"description":11,"timeFrame":16},"Revised Nottingham Sensory Assessment",{"measure":20,"description":11,"timeFrame":16},"Berg Balance Scale",{"measure":22,"description":11,"timeFrame":16},"Motor Activity Log",{"measure":24,"description":11,"timeFrame":16},"ABILHAND Questionnaire",{"measure":26,"description":11,"timeFrame":16},"Chedoke Arm and Hand Activity Inventory",{"measure":28,"description":11,"timeFrame":16},"Stroke Impact Scale",{"measure":30,"description":11,"timeFrame":16},"Stroke Self-Efficacy Questionnaire",{"allocation":32,"interventionModel":33,"interventionModelDescription":11,"primaryPurpose":34,"observationalModel":11,"timePerspective":11,"maskingInfo":35},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":36,"maskingDescription":11,"whoMasked":37},"SINGLE",[38],"OUTCOMES_ASSESSOR",[40,46,49],{"label":41,"type":42,"description":11,"interventionNames":43},"High-dose enhanced mirror priming group","EXPERIMENTAL",[44,45],"Behavioral: Mirror priming","Behavioral: Conventional therapy",{"label":47,"type":42,"description":11,"interventionNames":48},"Low-dose enhanced mirror priming group",[44,45],{"label":50,"type":51,"description":11,"interventionNames":52},"Active control group","ACTIVE_COMPARATOR",[45],[54,59],{"type":55,"name":56,"description":57,"armGroupLabels":58,"otherNames":11},"BEHAVIORAL","Mirror priming","During the mirror priming process, the movement images of the participant's unaffected limb are mirrored to the affected side to provide visual feedback.",[41,47],{"type":55,"name":60,"description":61,"armGroupLabels":62,"otherNames":11},"Conventional therapy","Conventional therapy is individualized and may include impairment-oriented, shaping, or whole-task practice.",[50,41,47],[64],{"name":65,"role":66,"phone":67,"phoneExt":68,"email":69},"Yi-chun Li, PhD","CONTACT","+886-7-6151100","7514","joyjoyfish@gmail.com",[71],{"facility":72,"status":73,"city":74,"state":75,"zip":76,"country":77,"countryCode":78,"cosmosGeoPoint":79,"geoPoint":84,"contacts":85},"E-Da Hospital","RECRUITING","Kaohsiung City","Yanchao District","82445","Taiwan","TW",{"type":80,"coordinates":81},"Point",[82,83],120.31333,22.61626,{"lat":83,"lon":82},[86],{"name":65,"role":66,"phone":67,"phoneExt":68,"email":69},{"type":88,"investigatorFullName":89,"investigatorTitle":90,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Yi-chun Li","Principal Investigator","100617873","hybrid-stroke-rehab-with-mirror-priming-100617873",false,"NCT07324278","Hybrid Stroke Rehab With Mirror Priming","Hybrid Stroke Rehabilitation With Mirror Priming","Inclusion Criteria:\n\n1. A first-ever unilateral stroke ≥3 months\n2. Age between 20 and 80 years\n3. Baseline Fugl-Meyer Assessment Upper Extremity (FMA-UE) score ≥ 10\n4. No severe spasticity in any joints of the affected arm\n5. Ability to follow the instructions\n6. No participation in other studies during the study period\n7. Willingness to provide informed written consent.\n\nExclusion Criteria:\n\n1. Serious medical problems or poor physical conditions that might be detrimental to study participation.\n2. Received or planned botulinum toxin injections within 3 months prior to or during the trial","ALL","20 Years","80 Years",{"count":102,"type":103},81,"ESTIMATED","INTERVENTIONAL",[106],"NA","This trial aims to examine the effects of enhanced mirror priming, overcoming the limitations of traditional mirror therapy, to achieve optimization and personalized intervention.",[109,110,111],"Cardiovascular Diseases","Stroke","Cerebrovascular Disorders",[113,114],"Rehabilitation","Mirror Therapy","2026-08-21",{"date":117,"type":118},"2026-08-25","ACTUAL",{"date":120,"type":118},"2026-02-02",{"date":122,"type":103},"2030-12-31",{"name":5,"class":6},1]